Home›Retrovir›Retrovir + Marnetegragene Autotemcel

Does Retrovir Interact with Marnetegragene Autotemcel?

Retrovir and Marnetegragene Autotemcel have a major drug interaction according to U.S. FDA drug labeling data. Do not take for one month prior to mobilization or expected duration for elimination, and until all apheresis cycles completed. May interfere with manufacturing of apheresed cells. The mechanism involves interference with manufacturing of apheresed cells. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Retrovir and Marnetegragene Autotemcel occurs because interference with manufacturing of apheresed cells. Clinically, this means do not take for one month prior to mobilization or expected duration for elimination, and until all apheresis cycles completed. may interfere with manufacturing of apheresed cells. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Retrovir and your doctor is considering prescribing Marnetegragene Autotemcel (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Retrovir+💊 Marnetegragene Autotemcel(Kresladi)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:betibeglogene autotemcel

What this means in plain English

Do not take for one month prior to mobilization or expected duration for elimination, and until all apheresis cycles completed. May interfere with manufacturing of apheresed cells.

What the FDA label says

"Interference with manufacturing of apheresed cells"

📖 Source: NLP:betibeglogene autotemcel

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Retrovir and Marnetegragene Autotemcel against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.